BTRX-335140 is a selective and orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively. Navacaprant endows with favorable in vitro ADMET and in vivo pharmacokinetic profiles and medication-like duration of action in rats.
Orally administered BTRX-335140 (CYM-53093) showed robust efficacy in antagonizing KOR agonist-induced prolactin secretion and in tail-flick analgesia in mice.
| Molecular Weight | 453.55 |
| Formula | C25H32FN5O2 |
| CAS Number | 2244614-14-8 |
| Solubility (25°C) | DMSO ≥ 10 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
| Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
| Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
| Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
| Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
| Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
| Related Opioid Receptor Products |
|---|
| ASP8062
ASP8062 is an orally active GABAB receptor-positive altered modulator (PAM) that can be used in studies related to opioid-related disorder (OUD). |
| Akuammidine
Akuammidine, isolated from the seeds of Picralima nitida, shows a preference for μ-opioid binding sites with Ki values of 0.6, 2.4 and 8.6 μM at μ-, σ- and κ-opioid binding sites, respectively. Akuammidine possesses anti-inflammatory and anti-asthmatic properties. |
| TRV734
TRV734 is an orally bioavailable G-protein-biased ligand for the μ-opioid receptor and an agonist for the μ-opioid receptor. |
| TRV250
TRV250 is a novel delta-like opioid receptor (DOR) small molecule agonist that preferentially selects G-protein signaling with relatively little activation of the β-arrestin2 post-receptor signaling pathway. |
| TRV-130 fumarate
TRV-130 fumarate is a biased agonist of the mu-opioid receptor (MOR) and can be used in studies related to acute pain. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
